
Day 3 Recap: SDPA Fall 2024
Key Takeaways
- Interdisciplinary collaboration between podiatry and dermatology is crucial for effective nail disorder management.
- Secukinumab shows promise in treating hidradenitis suppurativa and associated psychiatric symptoms.
Catch up on coverage from the third day of the 2024 Society of Dermatology Physician Associates Fall Conference in Las Vegas, Nevada.
To stay informed with the latest conference insights,
Advancing Nail Disorder Care by Bridging Podiatry and Dermatology
At the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning between podiatry and dermatology.
Poster Shows Secukinumab Improves HS Symptoms and Psychiatric Comorbidities
Post-hoc analysis demonstrated secukinumab's efficacy in addressing both HS and HS-related psychiatric symptoms.
Jane Mast, PhD, DMSc, MPAS: The 2024 Joe Monroe Lifetime Achievement Award Recipient
Jane Mast, PhD, DMSc, MPAS, shares her thoughts on the award, being a Derm PA, and dermatology.
Collaborating for Better Care: SDPA's Role in Advancing Dermatology
At the 2024 SDPA Fall Conference, Renata Block, MMS, PA-C, emphasized the power of membership, tailored education, interdisciplinary collaboration, and advocacy in shaping the future of dermatology to improve patient outcomes.
“Don’t Touch This”: Contact Dermatitis Insights and Updates from Matthew Zirwas, MD
Zirwas spoke with Dermatology Times to share the top clinical pearls and key takeaways from his discussion on contact dermatitis.
When and How to Biopsy Vulvovaginal Skin Conditions
At the 2024 SDPA Fall Conference, Audrey Rutherford, MD, discussed the critical role of vulvar biopsies in identifying cancer and other conditions to improve patient outcomes for underdiagnosed vulvar conditions.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















